Skip to search formSkip to main contentSkip to account menu

S 15261

Known as: S-15261, S15261 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Fluorenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Effects of S 15511, a therapeutic metabolite of the insulin‐sensitizing agent S 15261, in the Zucker Diabetic Fatty rat
Aim:  S 15261 is a novel oral antihyperglycaemic drug with both insulin secretagogue and insulin‐sensitizing effects. The study… 
2005
2005
S-15261, a new anti-hyperglycemic agent, reduces hepatic glucose production through direct and insulin-sensitizing effects.
2000
2000
Obesity: Adipogenesis and Insulin Resistance.
This meeting focused on the recent developments in the fields of adipogensis and insulin resistance. In particular, the molecular… 
1997
1997
S 15261, a novel agent for the treatment of insulin resistance. Studies on Psammomys obesus. Effect on pancreatic islets of insulin resistant animals.
A histological study has been conducted on pancreata from insulin resistant sand rats treated with S15261. As previously shown… 
1995
1995
S15261 antagonises amylin‐induced impaired glucose tolerance
1994
1994
S15261, a new compound for the treatment of the insulin resistance syndrome
SummaryA new oral agent, S15261 (the L-isomer of 3- [2- [2- [4- [2- [α-fluorenyl acetyl amino ethyl] benzoyloxy] ethyl amino] 1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)